Startups and Advocates Keep a Hopeful Eye on Biden’s Pick to Run the US Patent Office

Sam Blake

Sam primarily covers entertainment and media for dot.LA. Previously he was Marjorie Deane Fellow at The Economist, where he wrote for the business and finance sections of the print edition. He has also worked at the XPRIZE Foundation, U.S. Government Accountability Office, KCRW, and MLB Advanced Media (now Disney Streaming Services). He holds an MBA from UCLA Anderson, an MPP from UCLA Luskin and a BA in History from University of Michigan. Email him at samblake@dot.LA and find him on Twitter @hisamblake

Startups and Advocates Keep a Hopeful Eye on Biden’s Pick to Run the US Patent Office

After seven years trying to make it as an entrepreneur, Josh Malone's dreams and savings were running dry. With a growing family, urgency was mounting for his return to the safety and stability of corporate life. Desperate for a final crack, he asked his wife for patience and built one last prototype – a patented device that could quickly fill and tie multiple water balloons at once, which he called "Bunch O Balloons" – and started a Kickstarter campaign.

Malone raised nearly $1 million from 21,000 backers, and was invited on the national TV circuit, including a feature on the "Today Show."

"That's when it blew up," he recalled.


Malone struck a big deal with Zuru, a Los Angeles-based toy company, to exclusively license his patent, and his invention soon lined retail shelves across the country.

But he quickly learned that his patent, which was supposed to grant him legal recourse to prevent others from exploiting his invention for 20 years, hadn't deterred copycats, and that his ability to stop them wasn't as ironclad as he'd expected.

Patents can be the lifeblood of a startup and their immediate future will be shaped by the next head of the U.S. Patent and Trade Office (USPTO), which receives over 600,000 patent applications a year and sets the tone for how the executive branch enforces patent rights. Once small-time players like Google and Intel used patents to shoot ahead in their industries, along with many other founders who've leveraged patents to help raise money and protect investors. If the company fails, they may be able to sell the patents off to others.

Over the last 15 or so years, however, a combination of court decisions, regulatory changes and new legislation has weakened U.S. patent protection, leaving smaller patent owners few ways to prevent others from exploiting their inventions, according to USC law professor Jonathan Barnett.

Since 2006, the trend "has tended to favor the interests of larger firms and firms that use system or platform business models, like Google or Facebook, and disfavor entrepreneurs and firms that focus on innovation but don't necessarily convert those innovations into products for end-users, like Qualcomm, UCLA or BioNTech," said Barnett.

Startups often have a tougher time taking on established companies when patent rights are weakened, Barnett found after examining 116 years of U.S. patent and antitrust history for his latest book.

Patents can help startups raise money and attract partners and open doors to new markets. Established companies, on the other hand, can more easily self-finance commercialization of their innovations, said Bridget Smith, an L.A.-based patent lawyer who recently filed a brief to the U.S. Supreme Court arguing for stronger patent rights. Weaker patent rights often help incumbents fend off new competitors trying to grab a toehold in their market, she said.

As the Biden administration takes office, Smith, Malone and others concerned with how the government wields its patent policies are watching closely to see who will become the new leader of the USPTO.

"There are big debates about who the patent system benefits," said Barnett. Opponents to patent protection argue that patents slow innovation or increase prices, he said, but "empirical data is either uncertain or, in some cases, refutes these claims."

While changes under the outgoing USPTO director have slowly started to tilt the scales back toward stronger patent protection, Barnett said, "it will be interesting to see if the new administration reverts to the policies under the Obama administration, which was more patent-skeptical."

Who Will Be the Next USPTO Director?

It is too early to tell who Biden will pick to lead the USPTO. He has not publicly indicated who his choice will be, and the people he has surrounded himself with so far don't provide many clues about which way his appointee could lean.

Gina Raimundo is a former venture capitalist and current governor of Rhode Island.

On one hand, Gina Raimundo, a former venture capitalist and current governor of Rhode Island, is awaiting Senate confirmation to lead the Commerce Department, under which the USPTO falls. Based on her past career, she is "familiar" with IP and startups, said former USPTO Director David Kappos, suggesting that Raimundo may lean toward an inventor- and startup-friendly patent regime.

There are also indications, however, that Biden could take a harder line on patent-protection. He appointed UC Santa Clara law professor and former Obama IP-advisor Colleen Chien to his transition team, for instance. Chien has previously opposed the STRONGER Patents Act, legislation carried by Delaware Senator Chris Coons (D), who is now chairman of the Senate Subcommittee on Intellectual Property.

Traditionally, the appointment and confirmation of the USPTO director occurs after the secretary of commerce is confirmed. Should Raimundo's appointment go forward, Kappos said the new USPTO director appointee could enter the extensive vetting process by April and assume the position a few months later. At that point, the director will start to implement the direction that the Biden administration wants to take U.S. patent rights.

The Patent-Protection Pendulum

One key issue that the new director will have to weigh in on, and which has had a big influence on the recent push toward weaker patent protection, is how to subdue "patent trolls" — entities that accumulate patents with the sole purpose of suing companies for infringement. In many of those cases, companies settle out-of-court to avoid prolonged and expensive legal battles.

Ten years ago, in response to what he and others saw as "rampant abuse of the system" by patent trolls, Kappos oversaw the establishment of a new entity at the USPTO empowered to retrospectively invalidate patents. The Patent Trial and Appeal Board (PTAB) was hailed by proponents as an efficient and easy process to clean up the patent system, but critics say it went too far.

Particularly under Kappos' successor, former Google executive Michelle Lee, the PTAB "became a killing field for patents," said Brian Pomper, executive director of the Innovation Alliance, a pro-patent trade group that represents companies including Qualcomm and Dolby Labs.

Pomper said a recent series of rulings by the Supreme Court — motivated in part by a fear of patent trolls — has injected an unwelcome uncertainty over what is and isn't eligible for a patent, a sentiment echoed by multiple sources and shared by numerous current and former judges, appointees and legislators.

Smith and Pomper said the upshot of this uncertainty is weaker patent-rights and lower patent values.

Some politicians have taken note. Senator Coons, for example, has said that "U.S. patent law discourages innovation in some of the most critical areas of technology, including artificial intelligence, medical diagnostics and personalized medicine."

Of Balloons and Slingshots

Much of the support for the weakening of patent-protection has been backed by big tech lobbying at the expense of smaller, would-be competitors, according to critics like intellectual property lawyer Robert Taylor.

"In the matchup between David and Goliath, Goliath didn't need a slingshot; he only had to take David's away from him," said Taylor. "That's what large tech companies are doing with respect to small companies' patents."

It was against this backdrop that Malone's patent litigation battle unfolded.

Not long after Bunch O Balloons had arrived on retail shelves nationwide, TeleBrands – a large firm that invented the "As Seen On TV" method of selling products through pitchmen like Billy Mays – began selling a knock-off product.

From 2015 to 2019, Zuru, the L.A.-based company that had licensed Bunch O Balloons, pumped almost $100,000 a week into litigation and attorney and expert fees to sue TeleBrands, ultimately spending "$20 million in legal costs fighting over a stupid water balloon intellectual property," Malone said.

Ultimately, they prevailed. TeleBrands and several retailers were ordered to pay Malone and Zuru $31 million for infringing on their patent. They were also forced to permanently stop selling the knock-off product. Bunch O Balloons has now done nearly half a billion dollars in total sales.

Malone, who has since gone on to work as a full-time volunteer for patent-protection advocacy group US Inventor, says he is a rare exception. If not for his deep-pocketed backer, he said, he would have been another victim of an intellectual property system that he sees as rigged against the little guy.

"The average patent trial is about $450,000," said Smith. "That's nothing to FAANG companies, but that could eat up a startup's entire funding."

Adding more certainty over patent-eligibility and mitigating the power of the PTAB to invalidate patents are steps that the outgoing USPTO director, Andrei Iancu, took to strengthen patent protection. These decisions, Smith said, helped provide confidence to investors and lawyers working on contingency that it's worth putting up the fight against infringers.

Such changes were never codified into law, however, and the next director could take a new approach.

"There really is a chance to make a break (from weaker patent-protection), or do business as usual," Smith said.

Malone hopes for a course correction from what he and others view as an overreaction. "The problem with the efforts to stop the so-called patent troll is that they have thrown the baby out with the bathwater," he said.

The new USPTO director will inherit that legacy – and the power to decide what to do about it.

https://twitter.com/hisamblake
samblake@dot.la
The LA Startup Taking on One of Parenting’s Most Frustrating Problems

🔦 Spotlight

Hello Los Angeles,

Every parent knows the feeling of becoming an overnight expert in something they never wanted to learn.

For families navigating developmental delays, behavioral health needs, autism, speech therapy, occupational therapy or pediatric mental health support, that learning curve can become a full-time job. Finding the right specialist is hard enough. Getting those specialists, pediatricians, insurers and families to actually coordinate with each other? That’s often where the system breaks.

That’s the problem Los Angeles-based Village is trying to solve.

The specialty pediatrics startup raised $9.5 million in seed funding this week, led by Upfront Ventures, with participation from Bling Capital, GTMFund and Perceptive Ventures.

Its AI-powered platform is designed to bring families, providers, pediatricians and payers into one coordinated care system for children with developmental, behavioral and mental health needs.

The company was born out of co-founder Brandon Terry’s personal experience navigating care for his daughter after she was diagnosed with a rare genetic condition. Like many parents, his family faced long waitlists, high out-of-pocket costs and a fragmented web of specialists who were not necessarily working from the same playbook.

The pitch is not simply “find a provider faster.” Village wants to coordinate the entire team around a child, including occupational therapists, speech-language pathologists, behavioral therapists and pediatricians. Its AI agent, Vera, is designed to help with the administrative drag that often slows pediatric practices down: scheduling, documentation, billing and care coordination.

The company’s raise also points to a less flashy, but deeply consequential corner of health tech: making complex care easier to navigate. In specialty pediatrics, the pain point is not always the quality of care itself. It is the space between appointments, referrals, insurance approvals and provider communication where families are often left to connect the dots themselves.

So far, Village says it has built a network of more than 400 independent pediatric specialty providers in Southern California and has contracts with major commercial insurers including Blue Cross & Blue Shield, Cigna and UnitedHealthcare. The new funding will help the company expand across Southern California, into other parts of California and eventually into new states.

In other words, the next wave of healthcare infrastructure may not look like one giant hospital system. It may look more like a connected network built around the people who have been holding the system together all along: families.

And yes, in this case, it really does take a Village.

Venture deals follow below.👇


🤝 Venture Deals

    LA Companies

    • MOSH, the brain health nutrition brand co-founded by Maria Shriver and Patrick Schwarzenegger, raised a $13M Series A led by Main Street Advisors to expand nationally across grocery retailers and accelerate product innovation. The Los Angeles-based company plans to use the funding to grow its retail footprint, including an upcoming Target launch, while expanding its lineup of brain-focused nutrition products with new high-protein bars designed to support both cognitive and physical performance. - learn more
    • Spring Labs raised $5M to expand its AI-native compliance platform for banks and fintechs, with the funding led by BankTech Ventures and Haymaker Ventures. The Marina del Rey-based company is building AI agents that automate complaint handling, dispute resolution, and other compliance workflows, helping regulated financial institutions scale operations more efficiently while maintaining oversight and auditability. - learn more
    • FlowPrompt.ai secured a strategic seed investment from ART Fund SP, part of ChainBLX SPC, as the company expands its AI orchestration platform designed to help developers build and manage complex AI workflows through a visual interface. Alongside the investment, the companies also launched a global AI hackathon and builder program that will give selected founders access to funding opportunities, platform tools, and a live investor pitch event in Los Angeles later this summer. - learn more
    • Chance Studios raised $3.2M to build a unified platform for trading card game collectors, aiming to bring inventory management, marketplace activity, and community features into a single ecosystem. The round was co-led by Makers Fund and Hashed, with participation from Arbitrum Gaming Ventures, GAM3GIRL VC, and others, as the company looks to modernize how collectors buy, track, and interact around physical and digital TCG assets. - learn more

    LA Venture Funds
    • Rebel Fund participated in Moritz’s $9M seed round, backing the AI-native law firm as it looks to automate large portions of routine corporate legal work. The company combines software with experienced attorneys to speed up contract drafting and review, and says it has already handled more than $2 billion worth of contracts across over 100 companies since launching earlier this year. - learn more
    • Rebel Fund participated in Corvera’s $4.2M seed round, backing the AI-native supply chain platform as it automates back-office operations for consumer packaged goods brands. The Y Combinator-backed startup is building AI agents that can handle workflows like order processing, invoicing, and demand planning across fragmented enterprise systems, helping brands scale operations without significantly increasing headcount. - learn more
    • Chaac Ventures participated in Astrocade’s $5.6M funding round, backing the gaming startup as it builds a social gaming platform centered around community-created interactive experiences. The company is focused on blending gaming, streaming, and creator tools into a more collaborative entertainment platform, and plans to use the funding to expand development and grow its creator ecosystem. - learn more
    • Fusion VC participated in MSICS Pharma’s $3.6M funding round, backing the biotech company as it advances psilocybin-based treatments for PTSD, depression, and OCD. The company is developing medical-grade psychedelic compounds and plans to use the funding to expand production, accelerate clinical trials, and prepare for broader commercialization as interest in psychedelic therapies continues to grow. - learn more
    • JAM Fund participated in Fun’s $72M Series A, backing the payments infrastructure startup as it scales its platform for moving money across fintech and digital asset applications. The round was co-led by Multicoin Capital and SignalFire, and the company plans to use the funding to expand internationally, pursue acquisitions, and deepen its infrastructure stack as demand grows for faster global payment systems. - learn more

    LA Exits

    • Tapin2 was acquired by Greater Sum Ventures, joining MyVenue as part of GSV’s expanded point-of-sale technology platform for stadiums, arenas and live entertainment venues. Tapin2 provides self-service, suite catering and mobile ordering technology for high-volume sports and entertainment venues, while MyVenue offers cloud-native POS software across concessions, premium seating, retail, in-seat ordering and other venue operations. Together, the companies say their technology is used in more than 70% of MLB and NFL stadiums. Terms of the transaction were not disclosed. - learn more
    • Motiv Space Systems signed a definitive agreement to be acquired by Rocket Lab, bringing its space robotics, motion control systems and precision spacecraft mechanisms into Rocket Lab’s growing space systems business. Motiv’s technology has supported major missions including NASA’s Mars Perseverance rover and lunar rover programs, and the company will be rebranded as Rocket Lab Robotics after the deal closes, which is expected in the second quarter of 2026. - learn more
    • Robyn was acquired by Los Angeles-based Tot Squad, bringing its AI-powered doula tool into Tot Squad’s broader support platform for expecting and new moms. Robyn’s AI was trained on more than 70,000 de-identified messages between parents and doulas, and the acquisition will help Tot Squad offer free, around-the-clock pregnancy and early motherhood guidance alongside access to human experts like doulas, lactation consultants and sleep coaches. Terms of the deal were not disclosed. - learn more

      Download the dot.LA App

      Match Goes Niche With $100M Move

      🔦 Spotlight

      Hello Los Angeles,

      It’s May, and LA is about to have one of its more important weeks.

      The Milken Institute Global Conference 2026 returns to Beverly Hills next week, bringing together thousands of investors, operators, policymakers, and executives. It’s one of the few places where public markets, private capital, and tech actually overlap in the same rooms, and where you can usually get an early read on what capital is leaning into before it fully shows up in the data.

      This year, one theme is already starting to surface. Platforms are getting more specific, not more broad.

      This week’s news is a good example.

      Match Group is investing $100 million into Sniffies, a fast-growing, location-based platform built for gay, bi, trans, and queer men. It’s a notable move for a company best known for mainstream dating apps like Tinder and Hinge, and it signals a deeper push into more niche, community-driven platforms.

      Sniffies operates very differently from traditional dating apps. It’s more real-time, more map-based, and more focused on immediacy than long-term matching. In other words, it’s built around behavior, not profiles.

      And that’s what makes the investment interesting.

      For years, the dominant strategy in consumer platforms was scale, build one product that works for everyone. But what we’re seeing now is the opposite. The platforms that are gaining traction tend to be the ones that understand a specific audience deeply and build for how that group actually behaves.

      Match leaning into that shift isn’t just about expanding its portfolio. It’s a recognition that growth is coming from focus.

      And in a city like Los Angeles, that’s usually where things start.

      Below are this week’s venture deals and fund announcements across LA 👇


      🤝 Venture Deals

        LA Companies

        • Illuminant Surgical raised an $8.4M seed round to accelerate the rollout of its real-time anatomical projection platform, which aims to give surgeons enhanced visibility during procedures. The company’s “Skylight” system is designed to project internal imaging directly onto the patient, improving precision and reducing risk, and the funding will support product development and early commercialization efforts. - learn more
        • Jupid raised $840K in early funding to support its AI-native accounting platform, which is designed to automate bookkeeping, tax filing, and compliance for small businesses directly within banking platforms. The company is building what it describes as an embedded “AI accountant” that integrates with financial institutions to streamline operations for entrepreneurs, and plans to use the funding to expand partnerships and accelerate product development as demand grows for automated financial tools. - learn more
        • Lumicup raised a $4.38M Series A to expand its product line and scale manufacturing as it looks to meet growing demand for its consumer health and wellness products. The company plans to use the funding to increase production capacity, invest in new product development, and strengthen its distribution as it continues to grow its footprint in the market. - learn more
        • Counterpart raised a $50M Series C to expand its AI-driven “agentic insurance” platform, which helps small businesses manage growing legal and employment risks tied to AI adoption. The round was led by Valor Equity Partners with participation from existing investor Vy Capital, bringing the company’s total funding to $106M, and the capital will be used to launch new insurance products, expand risk management capabilities, and scale its underwriting platform. - learn more
        • Nervonik raised a $52.5M Series B to advance its next-generation peripheral nerve stimulation technology, which aims to deliver more precise, personalized treatment for chronic pain. The round was led by Amzak Health with participation from Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, and Shangbay Capital, and the company plans to use the funding to accelerate clinical programs and move toward commercialization. - learn more
        • LighthouseAI raised an $8M Series A to expand its AI-powered platform that helps pharmaceutical companies manage state licensing and regulatory compliance. The round was led by Boxcars Ventures with participation from TGVP and existing investors, and the company plans to use the funding to enhance product development, improve service delivery, and support continued growth as it scales across the pharma supply chain. - learn more

        LA Venture Funds
        • MANTIS Venture Capital participated in Rogo’s $75M Series C, backing the AI platform as it builds autonomous financial agents designed to streamline complex workflows for banks and investment firms. The round was led by Sequoia Capital and included a mix of major financial institutions and venture firms, signaling strong demand for AI tools that can augment decision-making across high-stakes finance. - learn more
        • M13 participated in Chord’s $7M funding round, backing the AI commerce platform as it builds a “context layer” designed to unify fragmented data, tools, and workflows for retail brands. The round was led by Equal Ventures with participation from Chingona Ventures and CEAS Investments, and the company aims to help operators move beyond dashboards toward systems that can make real-time decisions and automate actions across the business. - learn more
        • Fika Ventures participated in Lumian’s funding round, backing the startup as it launches an AI-native Amazon agency designed to automate and optimize how brands operate on the marketplace. The company is focused on replacing traditional agency workflows with AI-driven systems that can manage everything from advertising to operations in real time, reflecting a broader shift toward automation in e-commerce. - learn more
        • Riot Ventures co-led True Anomaly’s $650M Series D, backing the defense space startup as it scales spacecraft, software, and autonomous systems designed for national security missions in orbit. The round values the company at around $2.2 billion and brings total funding to over $1 billion since its 2022 founding, and the company plans to use the capital to accelerate mission deployments, expand manufacturing, and grow its workforce as demand increases for space-based defense capabilities. - learn more
        • Clocktower Technology Ventures participated in Clarasight’s $11.5M Series A, backing the AI-powered travel and expense platform as it works to unify fragmented enterprise data into a single system. The round was led by AlleyCorp with participation from several travel and fintech-focused investors, and the company plans to use the funding to expand product development and scale go-to-market efforts as demand grows for AI-driven efficiency in corporate travel. - learn more
        • Halogen Ventures and Mucker Capital participated in SkyfireAI’s $11M seed round, backing the startup as it builds an AI-native platform for coordinating autonomous, multi-drone operations. The company’s software is designed for public safety and defense use cases, helping teams deploy and manage fleets of drones with greater speed and efficiency without increasing staffing, and it plans to use the funding to accelerate product development, expand its team, and scale deployments with government and mission-critical customers as demand grows for autonomous drone systems. - learn more
        • Matter Venture Partners led OpenLight’s $50M Series A-1, with participation from Acclimate Ventures, Catapult Ventures, and existing investors, backing the photonics company as it scales its next-generation chip platform for AI infrastructure. The funding brings total capital raised to $84M and will be used to accelerate global deployment of its silicon photonics technology across data centers, telecom, and other high-bandwidth applications. - learn more
        • Alexandria Venture Investments participated in Fathom Therapeutics’ $47M Series A, backing the biotech startup as it applies quantum chemistry and AI to design next-generation small molecule drugs. The oversubscribed round was led by Sutter Hill Ventures with participation from Chemistry and other investors, and the company plans to advance its platform, which simulates protein behavior inside living cells to accelerate drug discovery. - learn more

          Download the dot.LA App

          Netflix Doubles Down on LA

          🔦 Spotlight

          Hey Los Angeles.

          Goodbye Coachella, hello Stagecoach. The desert doesn’t stay quiet for long, and neither does LA’s entertainment machine.

          This week, that momentum showed up in a more permanent way.

          Netflix is expanding its footprint in Los Angeles with a major move to take over and invest in Radford Studio Center, a historic production lot in Studio City. The company is planning a long-term transformation of the site, with upgrades to soundstages, production offices, and infrastructure designed to support the next generation of film and television production.

          It’s a notable shift in a moment when production has been under pressure in California, with studios increasingly looking outside the state for cost advantages. Netflix going deeper in LA, and specifically into a legacy studio lot, signals a different kind of commitment. Not just to content, but to where that content actually gets made.

          And it comes at a time when the streaming wars have matured. Growth is harder, budgets are tighter, and the focus has shifted from scale at all costs to efficiency and control. Owning or operating more of the production environment gives Netflix tighter control over timelines, costs, and output.

          For Los Angeles, it’s a reminder of what still anchors the city. Even as AI, defense tech, and infrastructure startups continue to rise, entertainment remains one of the few industries where LA isn’t just competitive, it’s foundational.

          Different headlines each week, but a consistent theme underneath them. Whether it’s power, autonomy, or content, the companies that matter are investing in the layers they don’t want to outsource.

          And in this case, that layer is Hollywood itself.

          Below are this week’s venture deals, fund announcements, and acquisitions across LA 👇


          🤝 Venture Deals

            LA Venture Funds

            • UP Partners and Calm Ventures participated in Reliable Robotics’ $160M funding round, backing the autonomous aviation company as it advances pilotless flight technology for cargo and passenger aircraft. The round included a mix of new and existing investors, and the company plans to use the capital to accelerate certification efforts and expand deployment of its autonomous systems across commercial aviation. - learn more
            • Blue Heron Ventures participated in Tava Health’s $40M Series C, backing the company as it expands its tech-enabled mental health platform into a more integrated, full-stack system for providers, employers, and health plans. The round was led by Centana Growth Partners with participation from existing investors, and the company plans to use the funding to roll out new AI-powered tools and broaden access to care while reducing administrative friction across the system. - learn more
            • Vamos Ventures participated in Zócalo Health’s $15M Series A, backing the company as it scales its tech-enabled, community-based primary care model focused on high-need and underserved populations. The round was led by .406 Ventures with participation from existing and new investors, and the company plans to use the funding to expand its clinics and deepen partnerships with Medicaid programs as demand for accessible care grows. - learn more

            LA Exits
            • Studio71 has been acquired by Fixated as part of a broader deal in which German media company ProSiebenSat.1 sold its North American creator business, giving Fixated a large-scale network of creators and podcast operations and significantly expanding its footprint as it continues an aggressive roll-up strategy in the creator economy. The move signals continued consolidation in the space, with Fixated building a more vertically integrated platform across talent management, content production, and distribution. - learn more
            • Bonsai Health has been acquired by ModMed, bringing its AI-powered patient engagement platform into a broader healthcare software ecosystem. The deal is aimed at integrating Bonsai’s “agentic AI” capabilities into ModMed’s platform to automate patient outreach, fill care gaps, and improve scheduling across a network of nearly 50,000 providers. - learn more

              Download the dot.LA App

              RELATEDEDITOR'S PICKS
              Trending